Skip to content

Herpes Simplex Virus Antibody, Eye-Related (Qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test checks for antibodies to the herpes simplex virus (HSV) that may affect the eyes, helping identify past or current infection exposure.

Quick summary

["Determines if your body has developed immunity to HSV that could impact eye health."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
44511-4
Short code
HSV Ag Eye Ql
Synonyms
HSV Ag Eye Ql
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms like eye redness, pain, or discharge, or if you’ve had eye infections linked to HSV. It’s also used to monitor people with a history of eye herpes or those at higher risk, such as those with weakened immune systems.

What to Expect During the Test

The test involves collecting a small sample of blood from a vein in your arm. It’s quick and usually done in a doctor’s office or lab. No special preparation is needed, but let your provider know about any medications you’re taking.

How the Results Are Interpreted

Results are qualitative (yes/no) rather than quantitative. A positive result means your body has detected HSV antibodies, suggesting past exposure or current infection. A negative result indicates no detectable antibodies at this time.

Possible Outcomes and Next Steps

A positive result may prompt further testing or treatment to manage symptoms, especially if eye involvement is suspected. Follow-up may include antiviral medications or monitoring for recurrence. If results are negative but symptoms persist, other causes may be investigated.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

HSV Eye Antibody (Qualitative)

Frequently asked questions

What does a positive result mean?
A positive result indicates your immune system has recognized HSV antibodies, which could mean you’ve had HSV before or are currently infected. This may affect eye health, especially if symptoms like eye pain, redness, or discharge are present. Your provider will guide next steps based on your symptoms and medical history.
What if I have no symptoms but test positive?
Even without symptoms, a positive result means you may carry HSV antibodies. If this test was done for eye-related concerns, your provider may recommend monitoring or treatment to prevent complications. If you’re asymptomatic, discuss with your provider whether further testing or follow-up is needed.
Can this test be used to diagnose active eye infection?
This test detects antibodies but does not directly diagnose an active eye infection. If you suspect an eye infection, your provider may order additional tests or evaluate symptoms directly. Antibody presence alone doesn’t confirm active HSV eye disease without clinical correlation.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy